adrenergic beta-agonists

Preferred Label : adrenergic beta-agonists;

MeSH definition : Drugs that selectively bind to and activate beta-adrenergic receptors.;

MeSH synonym : beta-agonists, adrenergic; betamimetics; adrenergic beta agonist; beta adrenergic receptor agonist; adrenergic beta-agonist; adrenergic beta-receptor agonists; beta-receptor agonists, adrenergic; beta-adrenergic agonist; adrenergic beta receptor agonists; receptor agonists, beta adrenergic; beta-adrenergic receptor agonist; beta-receptor agonist, adrenergic; beta-agonist, adrenergic; receptor agonists, beta-adrenergic; agonists, beta-adrenergic; beta adrenergic agonists; beta-adrenergic agonists; agonists, adrenergic beta-receptor; beta-adrenergic receptor agonists; agonist, adrenergic beta-receptor; beta adrenergic agonist; agonist, beta-adrenergic; adrenergic beta receptor agonist; receptors agonists, adrenergic beta; agonist, beta-adrenergic receptor; agonists, beta-adrenergic receptor; adrenergic beta-receptor agonist; receptor agonist, beta-adrenergic; beta adrenergic receptor agonists; adrenergic beta agonists;

Wikipedia automatic translation : Clergy;

MeSH annotation : general or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-ANTAGONISTS; DF: ADREN BETA AGON or ADREN BETA AG; general or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-ANTAGONISTS;

Wikipedia link : https://en.wikipedia.org/wiki/Clergy;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000318;

UMLS CUI

C0001644;

ATC code(s)
- alpha- and beta-adrenoreceptor agonists [ATC Code]
- alpha- and beta-adrenoreceptor agonists [ATC Code]
- non-selective beta-adrenoreceptor agonists [ATC Code]
- non-selective beta-adrenoreceptor agonists [ATC Code]
- selective beta-2-adrenoreceptor agonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- beta sympathomimetic [CISMeF Querying Strategy]
CISMeF manual mappings
- Agonist predominantly beta-adrenoreceptor [ICD-11 Extension code]
- Beta-adrenoceptor agonist poisoning (disorder) [SNOMED CT concept]
- Predominantly beta-adrenoreceptor agonists [Bloc CIM-11]
Currated CISMeF NLP mapping
- Beta-Adrenergic Agonist [NCIt concept]
- Product containing beta adrenergic receptor agonist (product) [SNOMED CT concept]
- Substance with beta adrenergic receptor agonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 3-(butyl-4-(4-((2-hydroxy-2-(4-hydroxy-3-((methylsulfonyl)amino)phenyl)ethyl)amino)-1-piperidinyl)anilino)-3-oxopropanoic acid [MeSH Supplementary Concept]
- ICI 215001 [MeSH Supplementary Concept]
- SOM 1397CL [MeSH Supplementary Concept]
- lidamidine [MeSH Supplementary Concept]
- ro 40-2148 [MeSH Supplementary Concept]
- tetramethylpyrazine [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, adrenergic, beta [MeSH Descriptor]
Ne pas confondre avec
- adrenergic beta-antagonists [MeSH Descriptor]
Record concept(s)
- adrenergic beta-Agonists [MeSH concept]
SNOMED CT : is a
- isoproterenol [MeSH Descriptor]
See also (suggested by CISMeF)
- receptors, adrenergic, beta [MeSH Descriptor]
See also inter- (CISMeF)
- Beta adrenergic receptor agonist (disposition) [SNOMED CT concept]
- beta sympathomimetic [CISMeF Querying Strategy]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- BRL 26830A [MeSH Supplementary Concept]
- BRL 35135 [MeSH Supplementary Concept]
- BRL 37344 [MeSH Supplementary Concept]
- CGP 12177 [MeSH Supplementary Concept]
- ICI D7114 [MeSH Supplementary Concept]
- amibegron [MeSH Supplementary Concept]
- arbutamine [MeSH Supplementary Concept]
- befunolol [MeSH Supplementary Concept]
- bromoacetylalprenololmenthane [MeSH Supplementary Concept]
- broxaterol [MeSH Supplementary Concept]
- cimaterol [MeSH Supplementary Concept]
- clenbuterol [MeSH Descriptor]
- denopamine [MeSH Supplementary Concept]
- dopexamine [MeSH Supplementary Concept]
- epinephrine [MeSH Descriptor]
- higenamine [MeSH Supplementary Concept]
- isoproterenol [MeSH Descriptor]
- isoxsuprine [MeSH Descriptor]
- mabuterol [MeSH Supplementary Concept]
- methoxyphenamine [MeSH Supplementary Concept]
- nylidrin [MeSH Descriptor]
- oxyfedrine [MeSH Descriptor]
- racepinephrine [MeSH Descriptor]
- ractopamine [MeSH Supplementary Concept]
- reproterol [MeSH Supplementary Concept]
- rimiterol [MeSH Supplementary Concept]
- ro 363 [MeSH Supplementary Concept]
- tretoquinol [MeSH Descriptor]
- tulobuterol [MeSH Supplementary Concept]
- zinterol [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Agonist predominantly beta-adrenoreceptor [ICD-11 Extension code]
- Beta-Adrenergic Agonist [NCIt concept]
- Predominantly beta-adrenoreceptor agonists [Bloc CIM-11]
- Product containing beta adrenergic receptor agonist (product) [SNOMED CT concept]
- Substance with beta adrenergic receptor agonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients